NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Monday that its second quarter revenues increased 27 percent year over year.

For the three months ended June 30, the company posted $6.6 million in revenues, up from $5.2 million in the year-ago quarter, and above the average analyst estimate of $4.8 million. GenMark had preannounced in July its second quarter revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.